<DOC>
	<DOCNO>NCT00948909</DOCNO>
	<brief_summary>This efficacy safety study evaluate new treatment subject mild moderate Alzheimer 's Disease .</brief_summary>
	<brief_title>Efficacy Safety Study Subjects With Mild-to-Moderate Alzheimer 's Disease</brief_title>
	<detailed_description>This Phase 2 study design evaluate efficacy safety ABT-126 approximately 260 adult mild-to-moderate Alzheimer 's disease ( AD ) . Subjects randomized one four treatment group ( ABT-126 , donepezil , placebo ) 12-week Treatment Period . Acronyms list secondary outcome section , , find list acronym define : - MMSE - Mini Mental Status Exam - QoL-AD - Quality Life - Alzheimer 's Disease - CIBIC-plus - Clinician Interview-Based Impression Change - NPI - Neuropsychiatric Inventory - CSDD - The Cornell Scale depression Dementia - ADCS-ADL - Alzheimer 's Disease Cooperative Study - Activities Daily Living</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Donepezil</mesh_term>
	<criteria>The subject male female age 55 90 year , inclusive , Screening Visit 1 . The subject meet NINCDS/ADRDA criterion probable AD . The subject MiniMental Status Examination ( MMSE ) total score 10 24 , inclusive , Screening Visit 1 . The subject Modified Hachinski Ischemic Scale ( MHIS ) score less equal 4 Screening Visit 1 . If female , subject must postmenopausal least two year surgically sterile The subject identify , reliable , caregiver . The subject currently take take medication treatment Alzheimer 's disease dementia within 60 day prior Screening Visit 1 The subject history significant neurologic disease AD . In opinion investigator , subject clinically significant uncontrolled medical psychiatric illness . The subject report history discontinuation donepezil due lack efficacy . The subject history intolerance adverse reaction donepezil lead discontinuation . The subject know hypersensitivity donepezil , piperidine derivative , excipients either donepezil hydrochloride ABT126 formulation . Patient us nonprescribed drug abuse history drug alcohol abuse/dependence . Subjects AST ALT value Screening Visit 1 great equal 1.5fold upper limit normal ( ULN ) .</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>